Michael Lazarus Selected Research

Scopolamine (Hyoscine)

1/2020

High cortical delta power correlates with aggravated allodynia by activating anterior cingulate cortex GABAergic neurons in neuropathic pain mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Lazarus Research Topics

Disease

5	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2024 - 01/2014
4	Fever (Fevers) 07/2015 - 04/2006
3	Sleep Wake Disorders 01/2023 - 01/2019
3	Vascular Remodeling 10/2020 - 07/2013
3	Pain (Aches) 01/2020 - 02/2009
3	Inflammation (Inflammations) 01/2017 - 02/2009
2	Schizophrenia (Dementia Praecox) 01/2024 - 01/2023
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2023 - 01/2019
2	Mania (Manias) 01/2023 - 06/2020
2	Ulcerative Colitis 12/2020 - 01/2017
2	Hypoxia (Hypoxemia) 10/2020 - 03/2015
2	Pulmonary Hypertension 10/2020 - 03/2015
2	Infections 11/2019 - 07/2011
2	Flushing 01/2017 - 01/2017
2	Myocardial Infarction 01/2017 - 01/2017
2	Fistula 01/2013 - 08/2011
1	Chronic Pain 01/2024
1	Mental Disorders (Mental Disorder) 01/2024
1	Catalepsy 01/2024
1	Parkinsonian Disorders (Parkinsonism) 01/2024
1	Nervous System Diseases (Neurological Disorders) 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Narcolepsy 12/2021
1	Hypertension (High Blood Pressure) 01/2020
1	Ataxia (Dyssynergia) 01/2020
1	Intellectual Disability (Idiocy) 01/2020
1	Neuralgia (Stump Neuralgia) 01/2020
1	Sleep Deprivation 01/2020
1	Hyperalgesia 01/2020
1	Epilepsy (Aura) 01/2020
1	Neoplasms (Cancer) 11/2019
1	Insulin Resistance 01/2019
1	Obesity 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Colitis 01/2017
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2017
1	Peritonitis 01/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2017

Drug/Important Bio-Agent (IBA)

8	Prostaglandin D2IBA 12/2020 - 03/2014
7	ProstaglandinsIBA 01/2022 - 02/2009
4	Niacin (Nicotinic Acid)FDA LinkGeneric 12/2020 - 01/2017
4	Dinoprostone (PGE2)FDA Link 02/2016 - 04/2006
3	Dopamine (Intropin)FDA LinkGeneric 01/2024 - 02/2016
3	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2023 - 01/2019
2	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2024 - 06/2020
2	Cholinergic Agents (Cholinergics)IBA 01/2024 - 11/2019
2	Modafinil (Provigil)FDA Link 12/2021 - 01/2020
2	MonocrotalineIBA 10/2020 - 03/2015
2	CytokinesIBA 01/2020 - 01/2017
2	Caffeine (No Doz)FDA LinkGeneric 01/2019 - 07/2011
2	CholesterolIBA 01/2019 - 01/2017
2	LipopolysaccharidesIBA 02/2009 - 04/2006
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2024
1	Antipsychotic Agents (Antipsychotics)IBA 01/2024
1	Haloperidol (Haldol)FDA LinkGeneric 01/2024
1	Levodopa (L Dopa)FDA LinkGeneric 01/2024
1	levodopa receptorIBA 01/2024
1	Hypnotics and Sedatives (Sedatives)IBA 01/2023
1	BenzodiazepinesIBA 01/2023
1	Diazepam (Valium)FDA LinkGeneric 01/2023
1	DORA-22IBA 01/2023
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2023
1	Orexin Receptor AntagonistsIBA 01/2023
1	sulprostoneIBA 01/2022
1	Semaxinib (SU5416)IBA 10/2020
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2020
1	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 10/2020
1	Therapeutic UsesIBA 10/2020
1	Reserpine (Serpasil)FDA Link 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	InterferonsIBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	Lysine (L-Lysine)FDA Link 01/2020
1	Tryptophan (L-Tryptophan)FDA Link 01/2020
1	Scopolamine (Hyoscine)FDA Link 01/2020
1	Superoxides (Superoxide)IBA 01/2020
1	HydroxylysineIBA 01/2020
1	Fatty Acid-Binding ProteinsIBA 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	Adenosine (Adenocard)FDA LinkGeneric 01/2019
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2019
1	AdiponectinIBA 01/2019
1	ParvalbuminsIBA 12/2017
1	Designer DrugsIBA 12/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	sym-trinitrobenzeneIBA 01/2017
1	prostaglandin D2 receptorIBA 01/2017
1	MK-0524IBA 01/2017
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2017
1	Sulfonic AcidsIBA 01/2017
1	ZymosanIBA 01/2017
1	Dextran SulfateIBA 01/2017
1	gamma-Aminobutyric Acid (GABA)IBA 02/2016
1	Divalent CationsIBA 10/2015

Therapy/Procedure

4	Therapeutics 01/2017 - 08/2011
2	Ligation 01/2020 - 01/2017
1	Induced Hypothermia 01/2023